| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Andrew C. Cato | Q67292607 |
| P2093 | author name string | Khusru Asadullah | |
| Hartmut Rehwinkel | |||
| Heike Schäcke | |||
| P2860 | cites work | The GRIP1:IRF3 interaction as a target for glucocorticoid receptor-mediated immunosuppression | Q24299196 |
| Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38. | Q24537701 | ||
| A nuclear isoform of the focal adhesion LIM-domain protein Trip6 integrates activating and repressing signals at AP-1- and NF-kappaB-regulated promoters | Q24559978 | ||
| The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain | Q24600925 | ||
| Glucocorticoid receptor-JNK interaction mediates inhibition of the JNK pathway by glucocorticoids. | Q40240328 | ||
| Novel heterocyclic glucocorticoids: in vitro profile and in vivo efficacy | Q40439369 | ||
| Design and evaluation of novel nonsteroidal dissociating glucocorticoid receptor ligands | Q40513488 | ||
| Novel N-arylpyrazolo[3,2-c]-based ligands for the glucocorticoid receptor: receptor binding and in vivo activity | Q40561629 | ||
| Effects of cortisone acetate and pituitary ACTH on rheumatoid arthritis, rheumatic fever and certain other conditions | Q41067146 | ||
| MIF as a glucocorticoid-induced modulator of cytokine production | Q41296855 | ||
| Efficacy and safety of inhaled corticosteroids. New developments | Q41728966 | ||
| Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. | Q42135532 | ||
| Dual specificity phosphatase 1 (DUSP1) regulates a subset of LPS-induced genes and protects mice from lethal endotoxin shock. | Q42205530 | ||
| p65-activated histone acetyltransferase activity is repressed by glucocorticoids: mifepristone fails to recruit HDAC2 to the p65-HAT complex | Q43632130 | ||
| A nonsteroidal glucocorticoid receptor antagonist | Q44269097 | ||
| Is AL-438 likely to have fewer side effects than the glucocorticoids? | Q44494540 | ||
| Trifluoromethyl group as a pharmacophore: effect of replacing a CF3 group on binding and agonist activity of a glucocorticoid receptor ligand | Q46660753 | ||
| Homodimerization of the glucocorticoid receptor is not essential for response element binding: activation of the phenylethanolamine N-methyltransferase gene by dimerization-defective mutants | Q46771342 | ||
| Effects of dissociated glucocorticoids on OPG and RANKL in osteoblastic cells | Q46812650 | ||
| Essential role of MAPK phosphatase-1 in the negative control of innate immune responses | Q46902216 | ||
| Glucocorticoid induced the expression of mRNA and the secretion of lipocortin 1 in rat astrocytoma cells. | Q55478804 | ||
| Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects | Q24630458 | ||
| Activation functions 1 and 2 of nuclear receptors: molecular strategies for transcriptional activation | Q28191471 | ||
| Functional interactions between Stat5 and the glucocorticoid receptor | Q28294034 | ||
| Glucocorticoids inhibit MAP kinase via increased expression and decreased degradation of MKP-1 | Q28366337 | ||
| Therapeutic benefit of a dissociated glucocorticoid and the relevance of in vitro separation of transrepression from transactivation activity | Q31838655 | ||
| Target-specific utilization of transcriptional regulatory surfaces by the glucocorticoid receptor | Q33713336 | ||
| The glucocorticoid receptor blocks P-TEFb recruitment by NFkappaB to effect promoter-specific transcriptional repression. | Q33780734 | ||
| Thymosin beta 4 sulfoxide is an anti-inflammatory agent generated by monocytes in the presence of glucocorticoids | Q33882219 | ||
| Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits interleukin-1beta-induced histone H4 acetylation on lysines 8 and 12. | Q33915125 | ||
| Factor recruitment and TIF2/GRIP1 corepressor activity at a collagenase-3 response element that mediates regulation by phorbol esters and hormones | Q34083450 | ||
| A fully dissociated compound of plant origin for inflammatory gene repression | Q34115914 | ||
| Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10. | Q34155771 | ||
| A novel antiinflammatory maintains glucocorticoid efficacy with reduced side effects | Q34177254 | ||
| Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo | Q34435699 | ||
| Post-transcriptional and nongenomic effects of glucocorticoids. | Q34444573 | ||
| BAG-1 family of cochaperones in the modulation of nuclear receptor action. | Q34460136 | ||
| DNA binding of the glucocorticoid receptor is not essential for survival | Q34469789 | ||
| Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses | Q34479244 | ||
| Adverse effects of topical glucocorticosteroids | Q34480503 | ||
| Dynamic remodeling of transcription complexes by molecular chaperones | Q34784636 | ||
| Mechanisms involved in the side effects of glucocorticoids | Q35003894 | ||
| Drug discovery for inflammatory diseases | Q35207540 | ||
| The Glucocorticoid Receptor: Molecular Mechanism and New Therapeutic Opportunities | Q35560626 | ||
| Soft steroids: a new approach to the treatment of inflammatory airways diseases | Q35569055 | ||
| Review of the unique properties of budesonide | Q35595091 | ||
| The pursuit of differentiated ligands for the glucocorticoid receptor | Q35610713 | ||
| Novel ligands: fine tuning the transcriptional activity of the glucocorticoid receptor | Q35892903 | ||
| The glucocorticoid receptor as target for classic and novel anti-inflammatory therapy | Q35976426 | ||
| MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock | Q36227887 | ||
| New and improved glucocorticoid receptor ligands | Q36322079 | ||
| The DNA binding-independent function of the glucocorticoid receptor mediates repression of AP-1-dependent genes in skin | Q36326164 | ||
| Glucocorticoid receptor function in hepatocytes is essential to promote postnatal body growth | Q37092115 | ||
| Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor | Q38293939 | ||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 565-573 | |
| P577 | publication date | 2006-08-01 | |
| P1433 | published in | Experimental Dermatology | Q15749509 |
| P1476 | title | Insight into the molecular mechanisms of glucocorticoid receptor action promotes identification of novel ligands with an improved therapeutic index | |
| P478 | volume | 15 |
| Q57203553 | A screening assay for Selective Dimerizing Glucocorticoid Receptor Agonists and Modulators (SEDIGRAM) that are effective against acute inflammation |
| Q24644700 | BOL-303242-X, a novel selective glucocorticoid receptor agonist, with full anti-inflammatory properties in human ocular cells |
| Q33713394 | Cutaneous glucocorticosteroidogenesis: securing local homeostasis and the skin integrity |
| Q27649439 | Doubling the Size of the Glucocorticoid Receptor Ligand Binding Pocket by Deacylcortivazol |
| Q38007405 | Effects of glucocorticoids and exercise on pancreatic β-cell function and diabetes development |
| Q42131163 | Efficacy, safety and mechanism of action of modified-release prednisone in rheumatoid arthritis |
| Q26851382 | Genomic and non-genomic effects of glucocorticoids: implications for breast cancer |
| Q34819002 | Genomic and nongenomic effects of glucocorticoids |
| Q28708483 | Identification of new biomarker candidates for glucocorticoid induced insulin resistance using literature mining |
| Q33725761 | Mitogen-activated protein kinase phosphatase 1/dual specificity phosphatase 1 mediates glucocorticoid inhibition of osteoblast proliferation |
| Q36879844 | Prednisolone induces the Wnt signalling pathway in 3T3-L1 adipocytes. |
| Q45567424 | Primary aldosteronism patients show skin alterations and abnormal activation of glucocorticoid receptor in keratinocytes. |
| Q35023858 | REDD1 functions at the crossroads between the therapeutic and adverse effects of topical glucocorticoids |
| Q41282756 | Selective Activator of the Glucocorticoid Receptor Compound A Dissociates Therapeutic and Atrophogenic Effects of Glucocorticoid Receptor Signaling in Skin |
| Q47145773 | Selective Glucocorticoid Receptor Properties of GSK866 Analogs with Cysteine Reactive Warheads |
| Q34162283 | Synthesis, biology and clinical significance of pentacyclic triterpenes: a multi-target approach to prevention and treatment of metabolic and vascular diseases |
| Q38050401 | The multiple facets of glucocorticoid action in rheumatoid arthritis |
| Q36502963 | Transcriptome analysis of age-, gender- and diet-associated changes in murine thymus |
| Q43225993 | Unique response profile of trabecular meshwork cells to the novel selective glucocorticoid receptor agonist, GW870086X. |
Search more.